Daniel Durocher

Co-Founder at Repare Therapeutics

Daniel Durocher is a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute where he acts as Director of the Biomedical Program. He is also a Full Professor in the Department of Molecular Genetics at the University of Toronto. Dr. Durocher’s overarching interest lies in understanding how cells maintain genome integrity, with an emphasis on the detection, signaling and repair of DNA double-strand breaks.

Dr. Durocher is widely recognized for his use of functional genomics approaches to study the DNA damage response, and those efforts established ubiquitin as a key organizing molecule in DNA damage repair. Among the awards received by Dr. Durocher in recent years, particularly notable is the 2015 Paul Marks Prize for cancer research awarded by Memorial Sloan Kettering. In 2010, he was also named one of Canada’s Top 40 under 40, a prize that highlights exceptional contributions to Canadian society by individuals under 40 years of age in the arts, science and business spheres.

Dr. Durocher holds a B.Sc. from Université de Montréal, a Ph.D. from McGill University and he did his postdoctoral training at the University of Cambridge, UK.